Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115265) titled 'Exploring the predictive role of traditional and novel body mass indices, TyG and AIP and their modified indices, novel inflammatory markers, and modified lipid indices, either independently or in combination, for chronic diseases (MAFLD/sarcopenia/diabetic complications/cardiovascular and cerebrovascular diseases/osteoporosis, etc.)' on Dec. 24, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: he First Affiliated Hospital of Chongqing Medical University
Condition:
Chronic diseases: including MAFLD, sarcopenia, diabetes and its related complications, cardiovascular and cer...